io9 OncoGaze™ is an AI platform
for molecular profiling from routine clinical slides. The technology makes it possible to detect genomic biomarkers from digital slides, making access to treatment possible for all patients worldwide.
Equity in cancer care is the future.
Our technologies make precision medicine relevant for every cancer patient. io9 has made key scientific breakthroughs that improve cancer diagnosis, offer new targets for treatment, and that provide new therapeutic approaches to make cancer detection and care more equitable around the globe.
Meet the team.
io9 founders are successful serial entrepreneurs, internationally recognized scientists, and clinical luminaries in the fields of clinical oncology, immuno-oncology, and AI.